Common Stock, Redeemable Convertible Preferred Stock, and Stockholders' Equity (Deficit) | 13: Common Stock, Redeemable Convertible Preferred Stock, and Stockholders' Equity (Deficit) The authorized capital stock of the Company consists of 1,100,000,000 shares of stock, $ 0.0001 par value per share, of which 1,000,000,000 shares are designated as Common Stock and 100,000,000 shares are designated as Preferred Stock. Common Stock The Company has issued and outstanding 118,190,135 shares of Common Stock as of January 31, 2023. Holders of Common Stock are entitled to one vote for each share. Dividend Rights Subject to the preferences that may apply to any shares of the Company's preferred stock outstanding at the time, the holders of Common Stock will be entitled to receive dividends, out of funds legally available for the payment of dividends, if the Board of Directors, in its discretion, authorizes the issuance of dividends. The Company's Board of Directors has not declared any dividends related to Company Common Stock as of January 31, 2023, and through the date these financial statements were available to be issued. Right to Receive Liquidation Distributions If the Company becomes subject to a liquidation, dissolution, or winding-up, the assets legally available for distribution to the Company’s stockholders would be distributable ratably among the holders of Common Stock and any participating series of the Company’s Preferred stock outstanding at that time, subject to prior satisfaction of all outstanding debt and liabilities and the preferential rights and liquidation preferences of any outstanding Preferred Stock The Board of Directors of the Company has not issued any classes or series of preferred stock as of January 31, 2023, and through the date these financial statements were available to be issued. The Board of Directors of the Company is authorized, subject to limitations prescribed by law, to issue preferred stock in one or more series, to establish the number of shares to be included in each series, and to fix the designation, powers, preferences, voting power, and conversion rights of the shares of each series without further vote or action by the Company’s stockholders. The Board of Directors is empowered to increase or decrease the number of shares of any series of the Company’s Preferred Stock, but not below the number of shares of that series then outstanding, without any further vote or action by the Company’s stockholders. The Predecessor’s capital structure includes the following classes of securities: Predecessor Common Stock The Predecessor’s common stock contains the following rights: Liquidation Rights — In the event of any liquidation or dissolution of the Predecessor (“Liquidation Event”), the holders of predecessor's common stock are entitled to the remaining assets of the Predecessor legally available for distribution after the payment of the full liquidation preference for all series of the Predecessor's outstanding redeemable convertible preferred stock (“Preferred Stock”). Dividends and Voting Rights — The holders of the Predecessor's common stock are entitled to receive dividends if declared by the Predecessor, but not until all dividends on all series of the Predecessor's redeemable convertible preferred stock have been either paid or declared and segregated. Holders of the Predecessor's common stock have the right to one vote per share. Predecessor Redeemable Convertible Preferred Stock The Company’s redeemable convertible preferred stock consists of (in thousands, except share data): Predecessor February 1, 2022 to Year Ended August 3, 2022 January 31, 2022 Shares Issued and Amount Shares Issued and Amount Convertible preferred stock—Series E, $ 0.00001 19,033,653 shares; 28,354,249 ) 15,767,013 $ 36,291 15,227,437 $ 33,248 Convertible preferred stock—Series D, $ 0.00001 14,833,942 shares; 21,222,496 ) 13,871,547 21,067 13,871,547 21,067 Convertible preferred stock—Series D-2, $ 0.00001 993,868 shares 1,216,439 ) 993,868 1,451 993,868 1,451 Convertible preferred stock—Series D-1, $ 0.00001 5,878,303 8,094,053 ) 5,878,303 8,171 5,878,303 8,171 Convertible preferred stock—Series C-1, $ 0.00001 16,208,756 shares 14,037,000 ) 11,882,605 16,836 11,376,115 13,979 Convertible preferred stock—Series C, $ 0.00001 21,124,700 shares 19,999,999 ) 21,124,699 19,899 21,124,699 19,899 Convertible preferred stock—Series B, $ 0.00001 26,914,949 shares 22,124,088 ) 26,914,949 22,047 26,914,949 22,047 Convertible preferred stock—Series A, $ 0.00001 16,122,188 shares 10,246,261 ) 15,997,285 10,159 15,997,285 10,159 Convertible preferred stock—Series seed, $ 0.00001 9,198,372 shares 2,285,795 ) 9,198,372 2,208 9,198,372 2,208 121,628,641 $ 138,129 120,582,575 $ 132,229 Predecessor Redeemable convertible preferred stock — Series E — In September 2020, in connection with the Cyveillance Acquisition, the Predecessor issued 8,110,058 shares of Series E Predecessor redeemable convertible preferred stock (“Series E”) with a fair value of $ 2.09 per share. As a result of these shares being issued the Predecessor incurred issuance costs of $ 0.1 million. The difference between the carrying value of Series E and the liquidation preference of Series E, as defined below, is equal to the issuance costs. Such difference is not being accreted as Series E is not mandatorily redeemable, and the Predecessor did not believe that a deemed liquidation event was probable of occurring. Subsequent to September 2020, an additional 7,117,379 shares of Series E redeemable convertible preferred stock were issued with an aggregate fair value totaling approximately $ 16.4 million. Predecessor Redeemable convertible preferred stock — Series D, Series D-1, and Series D-2 — In December 2019, the Predecessor issued 13,871,547 shares of Series D Predecessor redeemable convertible preferred stock (“Series D”) at $ 1.529930 per share for aggregate proceeds of $ 21.2 million, less issuance costs of $ 0.2 million. The difference between the carrying value of Series D and the liquidation preference of Series D, as defined below, is equal to the issuance costs. Such difference is not being accreted as Series D is not mandatorily redeemable, and the Predecessor did not believe that a deemed liquidation event was probable of occurring. The sale of Series D on December 20, 2019, triggered the automatic redemption of the convertible notes. The outstanding principal and accrued interest on the notes payable of $ 8.6 million was redeemed for 5,878,303 shares of Series D-1 with a fair value per share of $ 1.39 and 993,868 shares of Series D-2 with a fair value per share of $ 1.46 . Therefore, as a result of the redemption, the Predecessor recorded redeemable convertible Series D-1 preferred stock of $ 8.2 million and redeemable convertible Series D-2 preferred stock of $ 1.5 million. The difference between the value of the Series D-1 and Series D-2 redeemable convertible preferred stock recorded of $ 9.6 million and the outstanding principal and accrued interest on the notes payable of $ 8.6 million was equal to $ 1.1 million, which was recorded as a loss on debt extinguishment. Predecessor Redeemable convertible preferred stock — Series C-1 — In May 2018, the Predecessor issued 11,376,115 shares of Series C-1 Predecessor redeemable convertible preferred stock (“Series C-1”) at $ 1.233901 per share for aggregate proceeds of $ 14.0 million, less issuance costs of $ 0.1 million. The difference between the carrying value of Series C-1 and the liquidation preference of Series C-1, as defined below, is equal to the issuance costs. Such difference is not being accreted as Series C-1 is not mandatorily redeemable, and the Predecessor did not believe that a deemed liquidation event was probable of occurring. Predecessor Redeemable convertible preferred stock — Series C — In April 2017, the Predecessor issued 21,124,699 shares of Series C Predecessor redeemable convertible preferred stock (“Series C”) at $ 0.946759 per share for aggregate proceeds of $ 20.0 million, less issuance costs of $ 0.1 million. The difference between the carrying value of Series C and the liquidation preference of Series C, as defined below, is equal to the issuance costs. Such difference is not being accreted as Series C is not mandatorily redeemable, and the Predecessor did not believe that a deemed liquidation event was probable of occurring. Predecessor Redeemable convertible preferred stock — Series B — In November 2015, the Predecessor issued 25,176,396 shares of Series B Predecessor redeemable convertible preferred stock (“Series B”) at $ 0.822 per share for aggregate proceeds of $ 20.7 million, less issuance costs of $ 0.1 million. The difference between the carrying value of Series B and the liquidation preference of Series B, as defined below, is equal to the issuance costs. Such difference is not being accreted as Series B is not mandatorily redeemable, and the Predecessor did not believe that a deemed liquidation event was probable of occurring. The sale of Series B on November 20, 2015, triggered the redemption of outstanding convertible notes payable held by several strategic investors of the Predecessor. The outstanding principal and accrued interest on the notes payable totaled $ 1.3 million, which was converted into 1,738,553 shares of Series B, with a value of $ 1.4 million. The difference of $ 0.1 million represents, on average, a 6.2 % discount on the selling price of Series B as required under the provisions of the convertible notes payable. The value of the discount was recognized on the date of the conversion. Predecessor Redeemable convertible preferred stock — Series A — In April 2014, the Predecessor issued 15,997,285 shares of Series A Predecessor redeemable convertible preferred stock (“Series A”) at $ 0.6405 per share for aggregate proceeds of $ 10.2 million, less issuance costs of $ 0.1 million. The difference between the carrying value of Series A and the liquidation preference of Series A, as defined below, is equal to the issuance cost. Such difference not being accreted as Series A is not mandatorily redeemable and the Predecessor did not believe that a deemed liquidation event was probable of occurring. Predecessor Series E, Series D-2, Series D-1, Series D, Series C-1, Series C, Series B, and Series A (collectively the “Series Preferred”) contain the following rights: Conversion and Redemption Provisions — Series Preferred is mandatorily convertible upon either a Qualified IPO, which is defined in the Predecessor’s certificate of incorporation as the closing of the sale of shares of Predecessor Common Stock to the public at a price of at least five (5) times the Predecessor Series D Original Issue Price (defined in the Predecessor’s certificate of incorporation as $ 1.529930 per share, subject to adjustment based on the occurrence of certain events) in a firm-commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933, as amended, resulting in at least $ 30,000,000 of proceeds, net of the underwriting discount and commissions, to the Predecessor or the vote of the holders of a majority of the Series Preferred and Series Seed and the vote of a holders a majority of the Series D, Series D-1 and Series D-2. The requisite holders approved the mandatory conversion of the Series Preferred by written consent on December 18, 2021. The holders of the Predecessor’s Series Preferred are entitled to convert their shares into Predecessor common stock on demand. The number of shares of Predecessor common stock issued upon conversion is determined based on the number of converted Series Preferred and the conversion ratio. The conversion ratio is calculated by dividing the original issue price by the conversion price then in effect. The conversion price can be adjusted based on the occurrence of certain events, as defined in the certificate of incorporation. The table below depicts the original issue date, original issue price, conversion price, and conversion ratio, including all changes to conversion prices and conversion ratios from each Series Preferred original issue date through January 31, 2022. Predecessor Preferred Stock Series Original Issue Date Effective Date of Conversion Price Original Issue Price Conversion Price Conversion Ratio Series A April 14, 2014 November 20, 2015 $ 0.640 $ 0.320 2.0 Series B November 20, 2015 November 20, 2015 $ 0.822 $ 0.411 2.0 Series C April 26, 2017 April 26, 2017 $ 0.947 $ 0.473 2.0 Series C-1 May 31, 2018 May 31, 2018 $ 1.234 $ 0.617 2.0 Series D December 20, 2019 December 20, 2019 $ 1.530 $ 0.765 2.0 Series D-1 December 20, 2019 December 20, 2019 $ 1.224 $ 0.612 2.0 Series D-2 December 20, 2019 December 20, 2019 $ 1.377 $ 0.688 2.0 Series E September 30, 2020 September 30, 2020 $ 1.862 $ 0.931 2.0 The Series Preferred is not mandatorily redeemable. The Series Preferred is contingently redeemable upon the occurrence of a deemed liquidation event and a majority vote of the holders of Series Preferred and Series Seed to redeem all outstanding shares of the Predecessor’s redeemable convertible preferred stock. The contingent redemption upon the occurrence of a deemed liquidation is not within the Predecessor’s control and therefore the Series Preferred is classified outside of permanent equity in mezzanine equity on the Predecessor’s Consolidated Balance Sheet. Liquidation Rights — In the event of any liquidation, the holders of shares of Series Preferred shall be entitled to be paid, on a pari passu basis, an amount per share equal to the original issue price, plus all declared but unpaid dividends prior to the payment of the liquidation preference for the holders of Series Seed or any distribution to holders of the Predecessor's common stock. Dividends — The holders of Predecessor's Series Preferred are entitled to receive noncumulative dividends in the amount of 8 % of the original issuance price if, and only if, declared by the Board. The holders of Series Preferred, prior to, and in preference to, any dividends paid on Series Seed and common stock. Holders of Series Preferred are entitled to receive dividends on an as-if-converted basis at the same rate as common stockholders, if and when dividends are declared, and are entitled to a number of votes per share equal to the number of shares of common stock into which such shares are convertible. As of January 31, 2022, no dividends have been declared or paid. Voting Rights — Voting rights are consistent with the rights of holders of common stock, except for special rights to approve certain Predecessor actions or appoint a member of the Board, except as otherwise required by law. Predecessor Redeemable convertible preferred stock — Series Seed — On June 21, 2013, the Predecessor issued 7,645,871 shares of Series Seed at $ 0.2485 per share for aggregate proceeds of $ 1.9 million, less offering costs of $ 0.1 million. One of the investors who purchased Series Seed on June 21, 2013, also received a warrant, at no additional cost, to acquire an additional 115,000 shares of Series Seed at $ 0.01 per share. The cash proceeds received on the initial sale of Series Seed were first allocated to the fair value of the warrant issued and recorded as a warrant liability in the amount of $ 0.03 million, with the remainder of the cash proceeds, totaling $ 1.9 million, allocated to the carrying value of Series Seed. The sale of Series Seed on June 21, 2013, triggered the redemption of outstanding convertible notes payable held by early investors in the Predecessor. The outstanding principal and accrued interest on the notes payable totaled $ 0.3 million, which was converted into 1,437,501 shares of Series Seed, with a value of $ 0.4 million. The difference of $ 0.1 million represents a 20 % discount on the selling price of Series Seed as required under the provisions of the notes payable. The value of the discount was recognized on the date of conversion. On June 26, 2013, the warrant issued on June 21, 2013, was exercised. At exercise, the Predecessor issued 115,000 shares of Series Seed and recognized the value of Series Seed equal to the cash proceeds from the exercise of $ 1,150 , plus the fair value of the warrant as recognized on issuance of $ 0.03 million, for a total of $ 0.03 million. The difference between the carrying value of Series Seed and the liquidation preference of Series Seed, as defined below, is equal to the issuance costs, plus the fair value of the warrant on the date of grant. Such difference is not being accreted as Series Seed is not mandatorily redeemable, and the Predecessor did not believe that a deemed liquidation event was probable of occurring. Predecessor Series Seed contains the following rights: Conversion and Redemption Provisions — Series Seed is mandatorily convertible upon either a Qualified IPO, which is defined in the Predecessor’s certificate of incorporation as the closing of the sale of shares of Common Stock to the public at a price of at least five (5) times the Predecessor Series D Original Issue Price (defined in the Company’s certificate of incorporation as $ 1.529930 per share, subject to adjustment based on the occurrence of certain events) in a firm-commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933, as amended, resulting in at least $ 30,000,000 of proceeds, net of the underwriting discount and commissions, to the Predecessor or the vote of the holders of a majority of the Series Preferred and Series Seed and the vote of a holders a majority of the Series D, Series D-1 and Series D-2. The requisite holders approved the mandatory conversion of the Series Seed by written consent on December 18, 2021. The holders of the Series Seed are entitled to convert their shares into Predecessor common stock on demand. The number of shares of common stock issued upon conversion is determined based on the number of converted Series Seed and the conversion ratio, which varies based upon the occurrence of certain events. The conversion ratios for Series Seed are described in the table below. Predecessor Preferred Stock Series Original Issue Date Effective Date of Conversion Price Original Issue Price Conversion Price Conversion Ratio Seed Series June 21, 2013 June 21, 2013 $ 0.249 $ 0.249 1.0 Seed Series November 20, 2015 November 20, 2015 $ 0.249 $ 0.124 2.0 The Series Seed is not mandatorily redeemable. The Series Seed is contingently redeemable upon the occurrence of a deemed liquidation event and a majority vote of the holders of Series Preferred and Series Seed to redeem all outstanding shares of the Predecessor’s redeemable convertible preferred stock. The contingent redemption upon the occurrence of a deemed liquidation is not within the Predecessor’s control and therefore the Series Seed is classified outside of permanent equity in mezzanine equity on the Predecessor’s Consolidated Balance sheet. Liquidation Rights — In the event of any liquidation event, the holders of shares of Series Seed are entitled to an amount per share equal to the original issue price, plus all declared but unpaid noncumulative dividends, after the payment of the full liquidation preference to Series A, Series B, Series C, Series C-1, Series D, Series D-1 and Series D-2, but prior to any distributions to holders of common stock. Dividends and Voting Rights — The holders of Series Seed are entitled to receive noncumulative dividends in the amount of 8 % of the original Series Seed issue price if, and only if, declared by the Board. Holders of Series Seed are entitled to receive dividends on an as-if-converted basis at the same rate as common stockholders, if dividends are declared, and are entitled to the number of votes per share equal to the number of shares of common stock into which such shares are convertible. As of January 31, 2022, no dividends have been declared or paid. Voting rights are consistent with the rights of holders of common stock, except for special rights to approve certain Predecessor actions or appoint a member of the Board, except as otherwise required by law. The Company’s and Predecessor's common stock reserved for future issuance is as follows: Successor Predecessor January 31, 2023 January 31, 2022 Series Seed redeemable convertible preferred stock — 18,396,744 Series A redeemable convertible preferred stock — 31,994,570 Series B redeemable convertible preferred stock — 53,829,898 Series C redeemable convertible preferred stock — 42,249,398 Series C-1 redeemable convertible preferred stock — 22,752,230 Series D redeemable convertible preferred stock — 27,743,094 Series D-1 redeemable convertible preferred stock — 11,756,606 Series D-2 redeemable convertible preferred stock — 1,987,736 Series E redeemable convertible preferred stock — 30,454,874 Common stock warrants 16,213,430 1,924,790 Series A redeemable convertible preferred stock warrants — 249,806 Series B redeemable convertible preferred stock warrants — 292,682 Series C-1 redeemable convertible preferred stock warrants — 1,296,700 Series E redeemable convertible preferred stock warrants — 1,825,944 Stock options issued and outstanding 7,869,050 21,715,815 Restricted stock units issued and outstanding 2,802,426 — Sponsor earn-out shares 1,293,750 — Shares available for future grant under the 2022 plan 15,829,510 — Shares available for future grant under the 2013 plan — 1,193,436 44,008,166 269,664,323 14: Stock-Based Compensation Conversion of Stock-Based Awards As part of the Business Combination, the Company assumed all of the issued and outstanding options to purchase the Common Stock of ZeroFox, Inc. and IDX and converted them into options to purchase the Company's Common Stock (Company Options). The number of Company Options issued along with the associated strike prices were converted using the Exchange Ratios of the Business Combination (see Note 5). The Company issued options to purchase a total of 8,159,377 shares of the Company's Common Stock, 6,380,458 going to holders of options to purchase ZeroFox, Inc. common stock and 1,778,919 going to holders of options to purchase IDX common stock. The vesting schedules, remaining term, and provisions (other than the adjusted number of underlying shares and exercise prices) of the Company Options issued, are identical to the vesting schedules, remaining term, and other provisions of the ZeroFox, Inc. and IDX options that were converted. The conversion did not adjust vesting conditions of the options and did not require the Company to change the classification of the options. The Company recognized no incremental compensation cost as a result of the conversion. The Company recognized stock-based compensation expense based on the estimated fair value of the awards as calculated on their respective grant dates. The Company issued no stock options from the Closing Date of the Business Combination to January 31, 2023. ZeroFox Holdings, Inc 2022 Incentive Equity Plan On August 3, 2022, the Company adopted the 2022 ZeroFox Holdings, Inc. Incentive Equity Plan (the 2022 Plan). The 2022 Plan became effective on the closing of the Business Combination, which also occurred on August 3, 2022. The 2022 Plan provides for the issuance of up to 11,750,135 shares of Common Stock to employees, officers, directors, consultants, and advisors in the form of stock options, stock appreciation rights, restricted stock awards, restricted stock unit awards (RSUs), dividend equivalents, and other stock or cash-based awards. On November 30, 2022, the Board of Directors approved an increase to the number of shares available for issuance under the 2022 plan, effective January 1, 2023. Pursuant to the terms of the 2022 Plan agreement, the shares available for issuance increased by 5 % of the shares of Common Stock issued and outstanding at December 31, 2022, or 5,909,396 shares. As of January 31, 2023, there were 15,829,510 shares of Common Stock available for issuance under the 2022 Plan. Stock-based awards are granted at exercise prices not less than 100 % of the fair value of the stock at the date of grant. The Company determines fair value as the closing per share price of its Common Stock on the date the stock-based award is granted. The term of any stock-based award issued under the 2022 Plan may not exceed 10 years from the date of grant. The Company intends to issue new shares to satisfy share options upon exercise. ZeroFox Holdings, Inc. Employee Stock Purchase Plan On August 3, 2022, the Company adopted the ZeroFox Holdings, Inc. 2022 Employee Stock Purchase Plan (ESPP). The ESPP is designed to allow eligible employees of the Company and its subsidiaries to purchase shares of Company Common Stock with their accumulated payroll deductions. As of January 31, 2023, and through the date these financial statements were available to be issued, the Company had not implemented and made available the ESPP to its employees. Stock Options The Company estimates the fair value of stock options on the date of grant using the Black-Scholes option pricing model. The Black-Scholes option pricing model requires estimates of highly subjective assumptions, which affect the fair value of each stock option. As the Company did no t issue any stock options from the Closing Date of the Business Combination to January 31, 2023, this section describes how any such stock-based awards will be fair valued by the Company when they are issued. This section also describes how the Predecessor Companies valued their stock-based awards. Expected Volatility As the Company does not have a significant trading history of the shares of its Common Stock to date, the expected volatility will be based on the average historical stock price volatility of comparable publicly-traded companies in its industry peer group, financial, and market capitalization data. The Predecessor Companies utilized the same estimation approach. Expected Term The expected term of the Company’s options represents the period that the stock-based awards are expected to be outstanding. The Predecessor Companies utilized the same estimation approach. The Company will estimate the expected term of its employee awards using the SAB Topic 14 Simplified Method allowed by the FASB and SEC, for calculating expected term as it has limited historical exercise data to provide a reasonable basis upon which to otherwise estimate expected term. The Predecessor Companies utilized the same estimation approach. Certain of the Predecessor Companies' options began vesting prior to the grant date, in which case the Predecessor Company used the remaining vesting term at the grant date in the expected term calculation. Risk-Free Interest Rate The Company will estimate its risk-free interest rate by using the yield on actively traded non-inflation-indexed U.S. treasury securities with contract maturities equal to the expected term. The Predecessor Companies utilized the same estimation approach. Dividend Yield The Company has neither declared nor paid dividends to date and does not anticipate declaring dividends. As such, the dividend yield will be estimated to be zero. The Predecessor Companies utilized the same estimation approach. Fair Value of Underlying Common Stock The Company will use the closing price of its Common Stock (ZFOX) on the grant date of the stock-based award to represent the fair value of the underlying Common Stock. The Predecessor Companies' common stock was not publicly traded. As a result, the Predecessor Companies were required to estimate the fair value of their common stock. The Board of Directors of each respective Predecessor Company considered numerous objective and subjective factors to determine the fair value of the respective Predecessor Company’s common stock at each meeting in which awards are approved. The factors considered included, but were not limited to: (i) the results of contemporaneous independent third-party valuations of the respective Predecessor Company’s common stock; (ii) the prices, rights, preferences, and privileges of the respective Predecessor Company’s series of Preferred Stock relative to those of its common stock; (iii) the lack of marketability of the respective Predecessor Company’s common stock; (iv) actual operating and financial results of the respective Predecessor Company; (v) current business conditions and projections; (vi) the likelihood of achieving a liquidity event for the respective Predecessor Company, such as an initial public offering or sale of the Predecessor Company, given prevailing market conditions; and (vii) precedent transactions involving the respective Predecessor Company’s shares. The Company used the weighted-average assumptions in the table below to estimate the fair value of stock options. There are no values for the Successor as the Successor has not issued any stock options during the Successor Period. Successor Predecessor Assumptions January 31, 2023 August 3, 2022 January 31, 2022 Weighted-average risk-free rate N/A 1.48 % 1.42 % Weighted-average expected term of the option (in years) N/A 6.07 6.06 Weighted-average expected volatility N/A 38.92 % 38.09 % Weighted-average dividend yield N/A 0.00 % 0.00 % A summary of option activity for the Successor Period and the Year to Date Predecessor Period, is as follows (Aggregate Intrinsic Value in thousands): Successor Shares Weighted- Weighted- Aggregate Outstanding as of August 4, 2022 8,159,377 $ 1.5360 6.01 $ 17,004 Granted — — Exercised ( 206,476 ) 0.5952 Cancelled ( 83,851 ) 2.9681 Outstanding as of January 31, 2023 7,869,050 1.5454 6.07 16,325 Vested as of January 31, 2023 5,772,232 0.9591 5.39 15,359 Vested and expected to vest as 7,135,156 $ 1.3793 5.88 $ 15,987 Predecessor Shares Weighted- Weighted- Aggregate Outstanding as of February 1, 2022 21,715,815 $ 0.4398 6.28 $ 51,688 Granted 1,214,500 2.3920 Exercised ( 392,450 ) 0.2659 Cancelled ( 252,159 ) 1.4633 Outstanding as of August 3, 2022 22,285,706 0.5377 6.45 50,864 Vested as of August 3, 2022 14,783,495 0.2660 5.41 37,757 Vested and expected to vest as 19,659,894 $ 0.4662 6.17 $ 46,276 The Company did no t grant any options during the Successor Period. The weighted-average grant-date fair value of options granted during the Year to Date Predecessor Period and for the year ended January 31, 2022, was $ 1.0000 and $ 0.6709 , respectively. The total intrinsic value of options exercised during the Successor Period was $ 0.6 million. The total intrinsic value of options exercised during the Year to Date Predecessor Period and for the year ended January 31, 2022 was $ 1.0 million and $ 1.7 million, respectively. RSUs The fair value of RSUs is based on the closing price of our Common Stock on the date of grant. The Predecessor did no t grant RSUs during the Year to Date Predecessor Period or prior year ending January 31, 2022. A summary of RSU activity for the Successor Period is as follows: Successor Shares Weighted-Average Outstanding as of August 4, 2022 — $ — Granted 2,827,426 $ 4.64 Vested — $ — Cancelled ( 25,000 ) $ 4.63 Outstanding as of January 31, 2023 2,802,426 $ 4.64 RSUs granted under our stock incentive plans generally vest over a period of one to four years . Our outstanding RSUs vest upon the satisfaction of a service-based vesting condition. Stock-Based Compensation Expense The Company recognized non-cash, stock-based compensation expense in the accompanying Consolidated Statements of Comprehensive Loss for the Successor Period, the Year to Date Predecessor Period, and the year ended January 31, 2022, as follows (in thousands): Successor Predecessor August 4, 2022 to February 1, 2022 to Year Ended Cost of revenue - subscription $ 97 $ 18 $ 50 Cost of revenue - services 36 2 — Research and development 452 114 97 Sales and marketing 518 218 222 General and administrative 1,397 510 327 Total stock-based compensation expense $ 2,500 $ 862 $ 696 Unrecognized compensation cost related to outstanding stock options totaled $ 4.2 million as of January 31, 2023, which is expected to be recognized over a weighted-average remaining period of 2.4 years. Unrecognized compensation cost related to outstanding RSUs totaled $ 11.2 million as of January 31, 2023, which is expected to be recognized over a weighted-average remaining period of 3.3 years. 1 5: Income Taxes U.S. and foreign components of the loss before income taxes for the Successor Period, the Year to Date Predecessor Period, and the year ended January 31, 2022, were as follows (in thousands): Successor Predecessor August 4, 2022 to February 1, 2022 to Year Ended U.S. loss $ ( 734,326 ) $ ( 19,370 ) $ ( 40,031 ) Foreign income (loss) 3,157 ( 1,924 ) 1,056 Total | |